A quantitative benefit–risk analysis of chadox1 ncov-19 vaccine among people under 60 in italy
R Palladino, D Ceriotti, D De Ambrosi, M De Vito… - Vaccines, 2021 - mdpi.com
The Oxford-AstraZeneca ChAdOx1 nCoV-19 is a vaccine against the COVID-19 infection
that was granted a conditional marketing authorization by the European Commission in
January 2021. However, following a report from the Pharmacovigilance Risk Assessment
Committee (PRAC) of European Medicines Agency, which reported an association with
thrombo-embolic events (TEE), in particular disseminated intravascular coagulation (DIC)
and cerebral venous sinus thrombosis (CVST), many European countries either limited it to …
that was granted a conditional marketing authorization by the European Commission in
January 2021. However, following a report from the Pharmacovigilance Risk Assessment
Committee (PRAC) of European Medicines Agency, which reported an association with
thrombo-embolic events (TEE), in particular disseminated intravascular coagulation (DIC)
and cerebral venous sinus thrombosis (CVST), many European countries either limited it to …
A quantitative risk-benefit analysis of ChAdOx1 nCoV-19 vaccine among people under 60 in Italy
R Palladino, D Ceriotti, D De Ambrosi, M De Vito… - medRxiv, 2021 - medrxiv.org
ChAdOx1 nCoV-19 is a vaccine against the COVID-19 infection that was granted a
conditional marketing authorization by the European Commission in January 2021.
However, following a report from the Pharmacovigilance Risk Assessment Committee
(PRAC) of European Medicines Agency, which reported an association with thrombo-
embolic events (TEE), in particular Disseminated intravascular coagulation (DIC) and
Cerebral venous sinus thrombosis (CVST), many European countries either limited to …
conditional marketing authorization by the European Commission in January 2021.
However, following a report from the Pharmacovigilance Risk Assessment Committee
(PRAC) of European Medicines Agency, which reported an association with thrombo-
embolic events (TEE), in particular Disseminated intravascular coagulation (DIC) and
Cerebral venous sinus thrombosis (CVST), many European countries either limited to …